0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

PENICILLIN THERAPY IN HEMOLYTIC STREPTOCOCCIC PHARYNGITIS AND TONSILLITIS

NORMAN PLUMMER; DOROTHY RHOADES DUERSCHNER, A.B.; HAROLD DRAPER WARREN; FRANCIS T. ROGLIANO; RUELL A. SLOAN
JAMA. 1945;127(7):369-374. doi:10.1001/jama.1945.02860070001001.
Text Size: A A A
Published online

Despite the advances in chemotherapy, the development of an effective treatment of such a relatively common disease as hemolytic streptococcic pharyngitistonsillitis remains an important medical problem. Although the clinical value of the sulfonamides first was demonstrated against the hemolytic streptococcus,1 subsequent clinical observations have shown that this organism is relatively sulfonamide resistant when compared with the meningococcus, gonococcus and pneumococcus. Furthermore, some observers believe that the clinical courses of uncomplicated streptococcic pharyngitis-tonsillitis and scarlet fever are not alleviated or shortened by sulfonamide therapy,2 although it is generally accepted that complications occur less frequently in these diseases when the sulfonamides are used3 and the value of the sulfonamides in the treatment of hemolytic streptococcic otitis media, mastoiditis, meningitis and pneumonia is unquestioned. Since the introduction of penicillin, the superiority of this new drug over the sulfonamides in the serious hemolytic streptococcic infections has been demonstrated4 but its

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();